Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRM change at St. Jude

This article was originally published in The Gray Sheet

Executive Summary

Michael Coyle is transitioning out of his role of president of St. Jude Medical's Cardiac Rhythm Management Division (CRMD), the firm announces May 7, making way for Eric Fain, who takes over July 1. Fain has been at St. Jude for 20 years, holding the title of executive VP-development and clinical/regulatory affairs for CRMD since 2005. Coyle joined the firm in 1994 as director of business development, taking on his current position in 2001. Last week at the Heart Rhythm Society annual meeting in Denver, St. Jude displayed 12 new products, including its Altas II+HF cardiac resynchronization therapy defibrillator with atrial fibrillation suppression features (1"The Gray Sheet" March 26, 2007, p. 9)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024786

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel